The Potential Prognostic Marker TyG Index Predicts Time to Brain Metastasis at HER2 Positive Breast Cancer

References

• Sadeghi M, Kashanian S, Naghib SM, Arkan E. A high performance electrochemical aptasensor based on graphene decorated rhodium nanoparticles to detect HER2-ECD oncomarker in liquid biopsy. Sci Rep. 2022;12:3299. doi:10.1038/s41598-022-07230-3
   PubMed Web of Science ®Google Scholar
• Karakaya S, Karadag I, Ates O, Cakmak Oksuzoglu OB, Clinical Outcomes DU. Prognostic Factors in HER-2 Positive Breast Cancer with Brain Metastasis: a Single-centre Experience. J Coll Physicians Surg Pak. 2021;31:166–170.
   PubMed Web of Science ®Google Scholar
• Kennecke H, Yerushalmi R, Woods R, et al. Metastatic behavior of breast cancer subtypes. J Clin Oncol. 2010;28:3271–3277. doi:10.1200/JCO.2009.25.9820
   PubMed Web of Science ®Google Scholar
• Martin AM, Cagney DN, Catalano PJ, et al. Brain Metastases in Newly Diagnosed Breast Cancer: a Population-Based Study. JAMA Oncol. 2017;3:1069–1077. doi:10.1001/jamaoncol.2017.0001
   PubMed Web of Science ®Google Scholar
• Olson EM, Najita JS, Sohl J, et al. Clinical outcomes and treatment practice patterns of patients with HER2-positive metastatic breast cancer in the post-trastuzumab era. Breast. 2013;22:525–531. doi:10.1016/j.breast.2012.12.006
   PubMed Web of Science ®Google Scholar
• Leone JP, Leone BA. Breast cancer brain metastases: the last frontier. Exp Hematol Oncol. 2015;4:33. doi:10.1186/s40164-015-0028-8
   PubMedGoogle Scholar
• Parida PK, Marquez-Palencia M, Nair V, et al. Metabolic diversity within breast cancer brain-tropic cells determines metastatic fitness. Cell Metab. 2022;34(90–105.e7). doi:10.1016/j.cmet.2021.12.001
   PubMedGoogle Scholar
• Moreno-Sánchez R, Rodríguez-Enríquez S, Marín-Hernández A, Saavedra E. Energy metabolism in tumor cells. FEBS J. 2007;274:1393–1418. doi:10.1111/j.1742-4658.2007.05686.x
   PubMed Web of Science ®Google Scholar
• Jung YY, Kim HM, Koo JS. Expression of Lipid Metabolism-Related Proteins in Metastatic Breast Cancer. PLoS One. 2015;10:e0137204. doi:10.1371/journal.pone.0137204
   PubMed Web of Science ®Google Scholar
• Panigoro SS, Sutandyo N, Witjaksono F, et al. DK, Pranata R. The Association Between Triglyceride-Glucose Index as a Marker of Insulin Resistance and the Risk of Breast Cancer Front Endocrinol (Lausanne). 2021;12:745236.
   Google Scholar
• Pan K, Chlebowski RT, Mortimer JE, et al. Insulin resistance and breast cancer incidence and mortality in postmenopausal women in the Women’s Health Initiative. Cancer. 2020;126:3638–3647. doi:10.1002/cncr.33002
   PubMed Web of Science ®Google Scholar
• Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer. Int J Biol Sci. 2011;7:1003. doi:10.7150/ijbs.7.1003
   PubMed Web of Science ®Google Scholar
• Liu T, Zhang Q, Wang Y, et al. Association between the TyG index and TG/HDL-C ratio as insulin resistance markers and the risk of colorectal cancer. BMC Cancer. 2022;22:1007. doi:10.1186/s12885-022-10100-w
   PubMed Web of Science ®Google Scholar
• Alkurt EG, Özkan MB, Turhan VB. Predictive value of triglyceride/glucose index (TyG) in predicting breast cancer in patients with breast mass. Eur Rev Med Pharmacol Sci. 2022;26:4671–4676. doi:10.26355/eurrev_202207_29191
   PubMed Web of Science ®Google Scholar
• Fritz J, Bjørge T, Nagel G, et al. The triglyceride-glucose index as a measure of insulin resistance and risk of obesity-related cancers. Int J Epidemiol. 2020;49:193–204. doi:10.1093/ije/dyz053
   PubMed Web of Science ®Google Scholar
• Wang L, Zhang S, Wang X. The Metabolic Mechanisms of Breast Cancer Metastasis. Front Oncol. 2021;10:602416. doi:10.3389/fonc.2020.602416
   PubMed Web of Science ®Google Scholar
• Warburg O. On the origin of cancer cells. Science. 1956;123:309–314. doi:10.1126/science.123.3191.309
   PubMed Web of Science ®Google Scholar
• Kim S, Lee Y, Koo JS. Differential expression of lipid metabolism-related proteins in different breast cancer subtypes. PLoS One. 2015;10:e0119473. doi:10.1371/journal.pone.0119473
   PubMed Web of Science ®Google Scholar
• Albiges L, Andre F, Balleyguier C, Gomez-Abuin G, Chompret A, Delaloge S. Spectrum of breast cancer metastasis in BRCA1 mutation carriers: highly increased incidence of brain metastases. Ann Oncol. 2005;16:1846–1847. doi:10.1093/annonc/mdi351
   PubMed Web of Science ®Google Scholar
• Arnold SM, Young AB, Munn RK, Patchell RA, Nanayakkara N, Markesbery WR. Expression of p53, bcl-2, E-cadherin, matrix metalloproteinase-9, and tissue inhibitor of metalloproteinases-1 in paired primary tumors and brain metastasis. Clin Cancer Res. 1999;5:4028–4033.
   PubMed Web of Science ®Google Scholar
• Hiatt RA, Friedman GD, Bawol RD, Ury HK. Breast cancer and serum cholesterol. J Natl Cancer Inst. 1982;68:885–889.
   PubMedGoogle Scholar
• Howe GR, Aronson KJ, Benito E, et al. The relationship between dietary fat intake and risk of colorectal cancer: evidence from the combined analysis of 13 case-control studies. Cancer Causes Control. 1997;8:215–228. doi:10.1023/A:1018476414781
   PubMed Web of Science ®Google Scholar
• O’Neill S, O’Driscoll L. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies. Obes Rev. 2015;16:1–12. doi:10.1111/obr.12229
   PubMed Web of Science ®Google Scholar
• Sako A, Kitayama J, Kaisaki S, Nagawa H. Hyperlipidemia is a risk factor for lymphatic metastasis in superficial esophageal carcinoma. Cancer Lett. 2004;208:43–49. doi:10.1016/j.canlet.2003.11.010
   PubMed Web of Science ®Google Scholar
• Aljada A, Friedman J, Ghanim H, et al. Glucose ingestion induces an increase in intranuclear nuclear factor kappaB, a fall in cellular inhibitor kappaB, and an increase in tumor necrosis factor alpha messenger RNA by mononuclear cells in healthy human subjects. Metabolism. 2006;55:1177–1185. doi:10.1016/j.metabol.2006.04.016
   PubMed Web of Science ®Google Scholar
• Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. The product of fasting glucose and triglycerides as surrogate for identifying insulin resistance in apparently healthy subjects. Metab Syndr Relat Disord. 2008;6:299–304. doi:10.1089/met.2008.0034
   PubMedGoogle Scholar
• Navarro-González D, Sánchez-Íñigo L, Pastrana-Delgado J, Fernández-Montero A, Martinez JA. Triglyceride-glucose index (TyG index) in comparison with fasting plasma glucose improved diabetes prediction in patients with normal fasting glucose: the Vascular-Metabolic CUN cohort. Prev Med. 2016;86:99–105. doi:10.1016/j.ypmed.2016.01.022
   PubMed Web of Science ®Google Scholar
• Low S, Khoo KCJ, Irwan B, et al. The role of triglyceride glucose index in development of Type 2 diabetes mellitus. Diabetes Res Clin Pract. 2018;143:43–49. doi:10.1016/j.diabres.2018.06.006
   PubMed Web of Science ®Google Scholar
• Sánchez-Íñigo L, Navarro-González D, Fernández-Montero A, Pastrana- Delgado J, Martínez JA. The TyG index may predict the development of cardiovascular events. Eur J Clin Investig. 2016;46:189–197. doi:10.1111/eci.12583
   PubMed Web of Science ®Google Scholar
• Braun S, Bitton-Worms K, LeRoith D. The link between the metabolic syndrome and cancer. Int J Biol Sci. 2011;7:1003–1015.
   PubMed Web of Science ®Google Scholar
• Battelli MG, Bortolotti M, Polito L, Bolognesi A. Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase. Redox Biol. 2019;21:101070. doi:10.1016/j.redox.2018.101070
   PubMed Web of Science ®Google Scholar
• Doyle SL, Donohoe CL, Lysaght J, Reynolds JV. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nutr Soc. 2012;71:181–189. doi:10.1017/S002966511100320X
   PubMed Web of Science ®Google Scholar
• Khan KH, Yap TA, Yan L, Cunningham D. Targeting the PI3K-AKT-mTOR signaling network in cancer. Chin J Cancer. 2013;32:253–265. doi:10.5732/cjc.013.10057
   PubMed Web of Science ®Google Scholar
• Shi H, Zhou L, Yang S, Zhou H. The relationship between Triglyceride and glycose (TyG) index and the risk of gynaecologic and breast cancers. Clin Nutr ESPEN. 2022;51:345–352. doi:10.1016/j.clnesp.2022.08.004
   PubMed Web of Science ®Google Scholar
• Yan X, Gao Y, Tong J, Tian M, Dai J, Zhuang Y. Association Between Triglyceride Glucose Index and Non-Small Cell Lung Cancer Risk in Chinese Population. Front Oncol. 2021;11:585388. doi:10.3389/fonc.2021.585388
   PubMed Web of Science ®Google Scholar
• Okamura T, Hashimoto Y, Hamaguchi M, Obora A, Kojima T, Fukui M. Triglyceride-glucose index (TyG index) is a predictor of incident colorectal cancer: a population-based longitudinal study. BMC Endocr Disord. 2020;20:113. doi:10.1186/s12902-020-00581-w
   PubMed Web of Science ®Google Scholar
• Sekine Y, Koike H, Nakano T, Nakajima K, Suzuki K. Remnant lipoproteins stimulate proliferation and activate MAPK and Akt signaling pathways via G protein-coupled receptor in PC-3 prostate cancer cells. Clin Chim Acta. 2007;383:78–84. doi:10.1016/j.cca.2007.04.016
   PubMed Web of Science ®Google Scholar
• Taïb B, Aboussalah AM, Moniruzzaman M, et al. Lipid accumulation and oxidation in glioblastoma multiforme. Sci Rep. 2019;9:19593. doi:10.1038/s41598-019-55985-z
   PubMed Web of Science ®Google Scholar
• Liu H, Liu Z, Jiang B, et al. Prognostic Significance of Hyperglycemia in Patients with Brain Tumors: a Meta-Analysis. Mol Neurobiol. 2016;53:1654–1660. doi:10.1007/s12035-015-9115-4
   PubMed Web of Science ®Google Scholar
• van Duijnhoven FJ, Bueno-De-Mesquita HB, Calligaro M, et al. Blood lipid and lipoprotein concentrations and colorectal cancer risk in the European Prospective Investigation into Cancer and Nutrition. Gut. 2011;60:1094–1102. doi:10.1136/gut.2010.225011
   PubMed Web of Science ®Google Scholar
• Cedó L, Reddy ST, Mato E, Blanco-Vaca F, Escolà-Gil JCHDL, Potential New LDL. Players in Breast Cancer Development. J Clin Med. 2019;8:853. doi:10.3390/jcm8060853
   PubMed Web of Science ®Google Scholar
• Lofterød T, Mortensen ES, Nalwoga H, et al. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes. BMC Cancer. 2018;18:654. doi:10.1186/s12885-018-4568-2
   PubMed Web of Science ®Google Scholar